MedTrace Logo

Clinical Profile of Patients With Pulmonary Hypertension Due to Lung Diseases ( Single Center Experience)

NCT02774928 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2016-07-12

No results posted yet for this study

Summary

Development of pulmonary hypertension (PH) in chronic lung diseases has both functional and prognostic implications .

PH in Lung diseases is usually mild to moderate with preserved cardiac output, and evolves slowly alongside the progression of lung disease and hypoxemia .

However, a minority of patients develop severe PH with elevations in pulmonary artery pressure that have been described as ''out of proportion'' to the underlying disease .

The aim of this study is to compare the characteristics and outcomes of consecutive patients with PH-due to lung diseases diagnosed at our specialist referral center over a 1-year period.

Conditions

  • Pulmonary Hypertension

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mostafa I Elshazly, MD · Kasr Alaini school of Medicine

  • Yusif Amin, MD · Kasr Alaini school of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02774928 on ClinicalTrials.gov